Medeni, S. S. Et Al. 2018. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?. CLINICAL TRANSPLANTATION , vol.32, no.9 .

Medeni, S. S., Acar, C., Olgun, A., Acar, A., Seyhanli, A., Taskiran, E., ... Sevindik, O. G.(2018). Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?. CLINICAL TRANSPLANTATION , vol.32, no.9.

Medeni, Serife Et Al. "Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?," CLINICAL TRANSPLANTATION , vol.32, no.9, 2018

Medeni, Serife S. Et Al. "Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?." CLINICAL TRANSPLANTATION , vol.32, no.9, 2018

Medeni, S. S. Et Al. (2018) . "Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?." CLINICAL TRANSPLANTATION , vol.32, no.9.

@article{article, author={Serife Solmaz Medeni Et Al. }, title={Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?}, journal={CLINICAL TRANSPLANTATION}, year=2018}